Isokinetic Strengthening of Hip Muscles Effect on Pelvic Floor Muscles Function in Females With SUI (SUI)

Implications of Isokinetic Strengthening of Hip Muscles on Pelvic Floor Muscles Function in Women Experiencing Stress Urinary Incontinence

This study will be conducted to investigate the impact of isokinetic strengthening of hip muscles on pelvic floor muscles function in women experiencing stress urinary incontinence Does isokinetic strengthening of hip muscles impact pelvic floor muscles function in women experiencing stress urinary incontinence?

Study Overview

• Status: Enrolling by invitation
• Conditions: Stress Urinary Incontinence (SUI); Isokinetic Strengthening; Pelvic Floor Muscles
• Intervention / Treatment: Other: Pelvic floor muscles exercises; Other: Pelvic floor muscles exercises and isokinetic strengthening of hip muscles

• Study Type: Interventional
• Enrollment (Estimated): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Cairo, Egypt, 4914058
    • British University In Egypt

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Patients diagnosed with stress urinary incontinence
• age between 30 and 50 years

Exclusion Criteria:

• low back pain
• lower limb muscle pathology and/or joint degeneration
• cardiovascular, metabolic or pulmonary disease
• body mass index (BMI) > 30 kg/m2.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Control arm; Pelvic floor muscles exercises	Other: Pelvic floor muscles exercises; The exercises for strengthening the PFM were 10 contractions of 5 seconds, 15 contractions of 3 seconds, 20 contractions of 2 seconds, 20 contractions of 1 second (equal rest time between contractions), and 5 repetitions of maximum contractions while coughing (1-minute interval).25 The level of difficulty of the exercises throughout the 20 sessions was determined by the patient's position, starting in a supine position, then progressing to a sitting position and, finally, to a standing position
Experimental: Treatment arm; Pelvic floor muscles exercises and isokinetic strengthening of hip muscles	Other: Pelvic floor muscles exercises and isokinetic strengthening of hip muscles; The hip muscle strengthening exercise was executed on Biodex multi-joint system isokinetic dynamometer. Muscle tension of the lower limbs was relieved by executing 5-minute warm-up exercises using a cycle ergometer before execution of the isokinetic exercise For each hip muscle group, eight repetitions per set for 4 sets were carried out for a single exercise with a 30 second break between each set. The patient's position were the same positions used in the testing procedure. The exercises were carried out 3 times a week and the hip muscles strength evaluation was conducted after the end of the program intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pelvic floor muscle strength	Perineometry to measure vaginal squeeze pressure (in mm hg) the more the grade, the better the muscle strength and so the less the stress urinary incontinence	12 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Stress urinary incontinence.	- International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) to evaluate the frequency, severity and impact on quality of life) the less the grade, the better the muscle strength and so the less the stress urinary incontinence	12 weeks

Collaborators and Investigators

• Sponsor: British University In Egypt

Publications and helpful links

Helpful Links

• Related Info

Study record dates

Study Major Dates

• Study Start (Actual): January 23, 2025
• Primary Completion (Estimated): April 23, 2025
• Study Completion (Estimated): May 23, 2025

Study Registration Dates

• First Submitted: January 23, 2025
• First Submitted That Met QC Criteria: February 17, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: February 17, 2025
• Last Verified: January 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Urogenital Diseases; Mental Disorders; Male Urogenital Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urination Disorders; Lower Urinary Tract Symptoms; Urological Manifestations; Behavioral Symptoms; Elimination Disorders; Urinary Incontinence; Enuresis; Urinary Incontinence, Stress
• Other Study ID Numbers: P.T.REC/012/005601

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No